Literature DB >> 23974096

Molecular dynamics of the full-length p53 monomer.

Giovanni Chillemi1, Pavel Davidovich, Marco D'Abramo, Tazhir Mametnabiev, Alexander Vasilievich Garabadzhiu, Alessandro Desideri, Gerry Melino.   

Abstract

The p53 protein is frequently mutated in a very large proportion of human tumors, where it seems to acquire gain-of-function activity that facilitates tumor onset and progression. A possible mechanism is the ability of mutant p53 proteins to physically interact with other proteins, including members of the same family, namely p63 and p73, inactivating their function. Assuming that this interaction might occurs at the level of the monomer, to investigate the molecular basis for this interaction, here, we sample the structural flexibility of the wild-type p53 monomeric protein. The results show a strong stability up to 850 ns in the DNA binding domain, with major flexibility in the N-terminal transactivations domains (TAD1 and TAD2) as well as in the C-terminal region (tetramerization domain). Several stable hydrogen bonds have been detected between N-terminal or C-terminal and DNA binding domain, and also between N-terminal and C-terminal. Essential dynamics analysis highlights strongly correlated movements involving TAD1 and the proline-rich region in the N-terminal domain, the tetramerization region in the C-terminal domain; Lys120 in the DNA binding region. The herein presented model is a starting point for further investigation of the whole protein tetramer as well as of its mutants.

Entities:  

Keywords:  DNA damage; cancer; cell death; p53; p63; p73

Mesh:

Substances:

Year:  2013        PMID: 23974096      PMCID: PMC3875683          DOI: 10.4161/cc.26162

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  167 in total

1.  Immunologically distinct p53 molecules generated by alternative splicing.

Authors:  N Arai; D Nomura; K Yokota; D Wolf; E Brill; O Shohat; V Rotter
Journal:  Mol Cell Biol       Date:  1986-09       Impact factor: 4.272

2.  TP53INP1, a tumor suppressor, interacts with LC3 and ATG8-family proteins through the LC3-interacting region (LIR) and promotes autophagy-dependent cell death.

Authors:  M Seillier; S Peuget; O Gayet; C Gauthier; P N'Guessan; M Monte; A Carrier; J L Iovanna; N J Dusetti
Journal:  Cell Death Differ       Date:  2012-03-16       Impact factor: 15.828

3.  MicroRNA-128-2 targets the transcriptional repressor E2F5 enhancing mutant p53 gain of function.

Authors:  S Donzelli; G Fontemaggi; F Fazi; S Di Agostino; F Padula; F Biagioni; P Muti; S Strano; G Blandino
Journal:  Cell Death Differ       Date:  2011-12-23       Impact factor: 15.828

4.  Stability and structural recovery of the tetramerization domain of p53-R337H mutant induced by a designed templating ligand.

Authors:  Susana Gordo; Vera Martos; Eva Santos; Margarita Menéndez; Carles Bo; Ernest Giralt; Javier de Mendoza
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-21       Impact factor: 11.205

5.  Stage-specific sensitivity to p53 restoration during lung cancer progression.

Authors:  David M Feldser; Kamena K Kostova; Monte M Winslow; Sarah E Taylor; Chris Cashman; Charles A Whittaker; Francisco J Sanchez-Rivera; Rebecca Resnick; Roderick Bronson; Michael T Hemann; Tyler Jacks
Journal:  Nature       Date:  2010-11-25       Impact factor: 49.962

6.  Blockade of Hsp90 by 17AAG antagonizes MDMX and synergizes with Nutlin to induce p53-mediated apoptosis in solid tumors.

Authors:  A V Vaseva; A R Yallowitz; N D Marchenko; S Xu; U M Moll
Journal:  Cell Death Dis       Date:  2011-05-12       Impact factor: 8.469

Review 7.  Regulation of p73 activity by post-translational modifications.

Authors:  F Conforti; A E Sayan; R Sreekumar; B S Sayan
Journal:  Cell Death Dis       Date:  2012-03-15       Impact factor: 8.469

8.  Mantle cell lymphoma-like lymphomas in c-myc-3'RR/p53+/- mice and c-myc-3'RR/Cdk4R24C mice: differential oncogenic mechanisms but similar cellular origin.

Authors:  Pauline Rouaud; Rémi Fiancette; Christelle Vincent-Fabert; Virginie Magnone; Michel Cogné; Pierre Dubus; Yves Denizot
Journal:  Oncotarget       Date:  2012-05

9.  First-order rate-determining aggregation mechanism of p53 and its implications.

Authors:  GuoZhen Wang; Alan R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-06       Impact factor: 11.205

10.  Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells.

Authors:  Oliver D K Maddocks; Celia R Berkers; Susan M Mason; Liang Zheng; Karen Blyth; Eyal Gottlieb; Karen H Vousden
Journal:  Nature       Date:  2012-12-16       Impact factor: 49.962

View more
  17 in total

1.  Long-range regulation of p53 DNA binding by its intrinsically disordered N-terminal transactivation domain.

Authors:  Alexander S Krois; H Jane Dyson; Peter E Wright
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-12       Impact factor: 11.205

2.  Investigating Conformational Dynamics and Allostery in the p53 DNA-Binding Domain Using Molecular Simulations.

Authors:  Elena Papaleo
Journal:  Methods Mol Biol       Date:  2021

3.  Molecular mechanism of statin-mediated LOX-1 inhibition.

Authors:  Silvia Biocca; Federico Iacovelli; Sara Matarazzo; Giulia Vindigni; Francesco Oteri; Alessandro Desideri; Mattia Falconi
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

4.  Most Probable Druggable Pockets in Mutant p53-Arg175His Clusters Extracted from Gaussian Accelerated Molecular Dynamics Simulations.

Authors:  Morad Mustafa; Mohammed Gharaibeh
Journal:  Protein J       Date:  2022-01-31       Impact factor: 2.371

Review 5.  Structural Evolution and Dynamics of the p53 Proteins.

Authors:  Giovanni Chillemi; Sebastian Kehrloesser; Francesca Bernassola; Alessandro Desideri; Volker Dötsch; Arnold J Levine; Gerry Melino
Journal:  Cold Spring Harb Perspect Med       Date:  2017-04-03       Impact factor: 6.915

Review 6.  An integrated view of p53 dynamics, function, and reactivation.

Authors:  Özlem Demir; Emilia P Barros; Tavina L Offutt; Mia Rosenfeld; Rommie E Amaro
Journal:  Curr Opin Struct Biol       Date:  2021-01-02       Impact factor: 6.809

7.  TAp73 promotes anti-senescence-anabolism not proliferation.

Authors:  Massimiliano Agostini; Maria Victoria Niklison-Chirou; Maria Valeria Catani; Richard A Knight; Gerry Melino; Alessandro Rufini
Journal:  Aging (Albany NY)       Date:  2014-11       Impact factor: 5.682

Review 8.  Screening for E3-ubiquitin ligase inhibitors: challenges and opportunities.

Authors:  Vivien Landré; Barak Rotblat; Sonia Melino; Francesca Bernassola; Gerry Melino
Journal:  Oncotarget       Date:  2014-09-30

9.  Discovery of Novel Isatin-Based p53 Inducers.

Authors:  P Davidovich; V Aksenova; V Petrova; D Tentler; D Orlova; S Smirnov; V Gurzhiy; A L Okorokov; A Garabadzhiu; G Melino; N Barlev; V Tribulovich
Journal:  ACS Med Chem Lett       Date:  2015-07-06       Impact factor: 4.345

10.  p63 threonine phosphorylation signals the interaction with the WW domain of the E3 ligase Itch.

Authors:  Sonia Melino; Alessia Bellomaria; Ridvan Nepravishta; Maurizio Paci; Gerry Melino
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.